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The technique appeared to be especially well suited for newborn
mice, since at later intervals, e.g., at the age of three months,
details of the tissue structure were no longer as easily discerned
by electron microscopy as immediately after birth. Tissue in the
newborn mice is probably more loose allowing better penetration
of the fixatives and embedding medium into the cartilage.
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OSTEOARTHRITIS-RELATED PROTEINS IN HUMAN
ARTICULAR CHONDROCYTES: ROLE OF HSP90 IN
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Purpose: To analyze, by a proteomic approach, the protein
changes that are characteristic of OA chondrocytes, and identify
new OA-related proteins.
Methods: Chondrocytes were obtained from 10 OA patients
undergoing joint replacement, and from 10 cartilages from au-
topsies without history of joint disease. Whole cell proteins were
resolved by means of two-dimensional gel electrophoresis (2-
DE) and stained with SYPRORuby. Protein expression patterns
of gels from OA and normal chondrocyte proteins were analyzed
with PDQuest 7.3.1 software. OA-related proteins were identi-
fied by matrix-assisted laser desorption/ionization-time of flight
(MALDI-TOF) or MALDI-TOF/TOF mass spectrometry. Western
blot and immunohistochemistry analysis were performed with
a polyclonal anti-Hsp90β antibody. Interleukin-1β (5 ng/ml) and
Geldanamycin (1-1000 nM) were used to stimulate NO synthe-
sis and inhibit Hsp90, respectively. Normal chondrocytes were
treated with these compounds for up to 48 h prior to evaluation
of NO production by the Griess method.
Results: We examined an average of 700 protein spots that
were present in the different 2-DE gels. Both qualitative and
quantitative changes in protein expression patterns between
normal and OA chondrocytes were studied. Fifty nine protein
spots were found to be statistically increased or only present
in OA cells compared to the pattern of normal chondrocytes
(ratio OA:N ≥2.0, p<0.05), whereas 50 were decreased in OA
chondrocytes or only present in normal cells (ratio OA:N ≤0.5,
p<0.05). Many of these proteins were identified, and some of
them are shown in Table 1. According to their cellular role, 30% of
the over-expressed proteins were involved in cellular metabolism,
11% in cell signalling, 11% in protein targeting, 9% in protein
synthesis or turnover, 6% in transport processes, and 23% of
them were structural proteins. From the set of under-expressed
proteins, 33% of them were implicated in metabolism, 20% in cell
signalling, 17% in protein targeting, 8% in transport, 5% in protein
synthesis or turnover and 20% were structural. Validation of the
results was performed for the NOS positive modulator Hsp90β
Table 1. Some of the differentially expressed proteins identified between normal
and OA chondrocytes
Protein name Ratio Cellular role
OA:N
Heat shock 90kDa protein 1 beta 4.52 Chaperone, NO synthesis
Gelsolin [precursor] 3.20 Ca-sensitive actin depolymerizer
Collagen type VI, alpha 1 chain 2.50 ECM structure, cell adhesion
Glutathione transferase omega-1 2.31 Defence and stress
78 kDa glucose-regulated protein
[precursor] 2.25 Protein targeting
Glucosidase II, alpha subunit 2.12 Carbohydrate metabolism
Chloride intracellular channel
protein 1 0.62 Transport
both in cells (by Real Time - PCR and one- and two-dimensional
western blotting), and in cartilage (by immunohistochemistry).
Hsp90 inhibition by Geldanamycin reduces nitric oxide synthesis
to basal levels (from 78.6±6.62 to 6.83±1.02 μM nitrite, p<0.05)
in normal chondrocytes stimulated with IL-1β.
Fig 1. Two-dimensional Western blotting for examining Hsp90β over-expression
in OA chondrocytes.
Conclusions: This study describes the differences between the
protein profiles of normal and OA chondrocytes, pointing out
the intracellular protein changes that take part in osteoarthritis.
The effect of Hsp90 inhibition in preventing NO synthesis from
IL-1β-treated chondrocytes suggests the role of this chaperone
in the increase of NO production that occurs in OA cartilage.
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DIFFERENTIAL REGULATION OF UDP-GLUCOSE
DEHYDROGENASE EXPRESSION AND ACTIVITY IN
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Purpose: To investigate the mechanisms controlling gene ex-
pression and activity of uridine diphospho-glucose dehydroge-
nase (UGDH), a key enzyme involved in the biosynthesis of
the GAGs chain precursor, UDP-glucuronic acid, by several cy-
tokines and steroid hormones.
Methods: Articular chondrocytes (RAC) were isolated from 3-
week old rabbits and incubated for 24 hours with TGF-β (3 ng/ml),
IGF-I (10 ng/ml), IL-1β (1 ng/ml), IL-6 (25 ng/ml), 17β-estradiol
(0.1 nM), 5α-dihydrotestosterone (1 nM) and 17β-estradiol (0.1
nM) plus 5α-dihydrotestosterone (1 nM). Total RNA and proteins
were extracted and submitted to real time RT-PCR and Western
blotting to determine relative expression of the UGDH gene,
respectively. Spectrophotometric analysis was used to assay
the activity of the enzyme. In addition, transcriptional activity
of several UGDH gene promoter constructs was assayed, using
transient co-transfection of RAC with wild type or mutated human
estrogen receptor alpha gene (hERα66 or hERα46 respectively).
Results: We showed that steroids could exert positive regula-
tory effects at mRNA, protein and activity levels. In addition,
we demonstrated that hERα66, but not hERα46, increased the
transcriptional activity of UGDH gene. In contrast, no clear cor-
relation between transcriptional, translational and activity of the
UGDH was found for the effects of the cytokines studied. How-
ever, we observed that TGF-β enhanced the enzyme activity,
whereas IL-1β, IL-6 and IGF-I were without significant effect.
Conclusions: 17β-estradiol enhanced UGDH expression in rab-
bit articular chondrocytes. The effect is associated with an in-
crease of UGDH enzymatic activity. These studies provide in-
sights into the molecular mechanisms involved in the regulation
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of the UGDH gene and may offer new approaches to investigate
its potential alteration in joint diseases, including osteoarthritis
and rheumatoid arthritis.
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Purpose: Kashin-Beck Disease (KBD) is an endemic, chronic,
degenerative osteoarthropathy which affects 2.5 million of 30
million people living in the KBD region of China. The symptoms
include joint pain, stiffness of the joints after getting up in the
morning, disturbances of flexion and extension in the elbows,
enlarged phalangeal joints and limited motion in the middle-
sized and large joints of the body. It manifests as cartilage
degeneration and necrosis, with pathological changes occurring
in growth plate and articular cartilage. At present the etiology
and pathogenesis of KBD is unclear. One of the most popular
hypotheses is that KBD is caused by mycotoxins. The other
etiologies include selenium deficiency in soil and water in KBD
area, nutrition deficiency and virus infection etc. However, all of
the hypotheses lack adequate experimental evidence to support
any particular conclusion. This study investigated the extracellu-
lar matrix metabolism in cartilage and serum levels of IL-1 beta,
TNF-alpha, MMP-1 and CD44 in serum of KBD patients.
Methods: Immunohistochemical analyses of normal and KBD
patient cartilage (16 adults and 4 children and normal age-
matched patient tissue 4 adults and 3 children) was per-
formed using a monoclonal antibody recognising CD44, the
IGD aggrecase-generated neoepitope (monoclonal antibody BC-
13 recognising ... EGE373) and monoclonal antibody 3-B-3(-)
which recognizes thee nonreducing terminal of CS chains in
osteoarthritic cartilage. In addition, the serum levels of soluble
CD44 (sCD44), IL-1 beta, TNF-alpha and MMP-1 were deter-
mined in KBD patients (20 adults and 18 children) and normal
patients (20 adults and 18 children) using a competitive ELISA.
Results: Toluidine Blue and Saffron O staining indicated there
was a proteoglycan loss in both of KBD children and adult carti-
lage. Strong immunohistochemical staining for CD44 occurred in
14 of 16 adult KBD patients with moderate staining present in the
remaining two patients. Similarly, strong CD44 immunostaining
occurred in 3 of the 4 KBD children with moderate staining in the
fourth KBD child. In contrast, weak CD44 immunostaining was
only found in two of the four normal adult cartilage and none of
the three normal child samples. Immunohistochemical staining
with MAb BC-13 and 3-B-3(-) showed an intensive staining in
both of KBD children and adult cartilage when compared with
the normal cartilage samples. Furthermore, statistically signifi-
cant elevated levels of sCD44, IL-1 beta and TNF-alpha were
found in the sera of both adult and child KBD patients when
compared to serum levels of normal adult and child controls.
However, there was no difference in MMP-1 level between KBD
and normal children.
Conclusions: Our results demonstrate that altered IL-1 beta,
TNF-alpha, aggrecan and CD44 metabolism occurs in the
pathogenesis of KBD and there is an increased aggrecanase-
generated proteoglycan loss from KBD adult and children carti-
lage. These primary metabolic changes are a contributing factor
causing pathology in joint formation and instability which in turn
leads to the onset of secondary osteoarthropathy in the major
load-bearing joints of KBD patients.
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F.P. Lafeber
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Purpose: Joint bleeds occur frequently in patients suffering from
haemophilia or can occur as a consequence of a trauma. It
has been demonstrated that even a limited number of bleeds in
time leads to severe joint damage. With respect to the mech-
anisms of blood induced joint damage, we have demonstrated
that monocytes/macrophages within the mononuclear cell pop-
ulation together with the red blood cells as present in blood
are responsible for the irreversible inhibition of cartilage matrix
synthesis. Small amounts of IL-1 that are produced by activated
monocytes/macrophages increase the production of hydrogen
peroxide (H2O2) by chondrocytes. The hydrogen peroxide reacts
with haemoglobin-derived iron from damaged and phagocytosed
red blood cells, which results in the formation of hydroxyl radicals
in the vicinity of chondrocytes. This leads to chondrocyte apop-
tosis and with that the irreversible inhibition of cartilage matrix
synthesis.
In search of possible interventions to prevent or limit the cartilage
damaging effects of joint bleeds, we tested interleukin-10 (IL-
10) as an inflammation-controlling cytokine on blood-induced
cartilage damage.
Methods: Healthy human articular cartilage tissue explants were
cultured in the presence or absence of 50% v/v blood for 4 days,
followed by a recovery period of 12 days. IL-10 was added in
0.1, 1 or 10 ng/ml. The effect on cartilage matrix proteoglycan
synthesis, -release, and -content were determined.
Results: IL-10 was able to prevent the decrease in proteoglycan
synthesis and the increase in proteoglycan release of cartilage
exposed to blood dose dependently. As a consequence, the
decrease in proteoglycan content after blood exposure could be
prevented dose dependently. With 10 ng/ml IL-10, which is still a
low dose for local therapeutic treatment, at least 50% reduction
in adverse effects was observed.
Conclusions: The present results show that interleukin-10 pre-
vents the direct harmful effects of blood on articular cartilage.
This effect of IL-10, in addition to its anti-inflammatory prop-
erties, may add to prevention of irreversible degenerative joint
damage as a consequence in time of joint haemorrhages. Al-
though treatment studies in addition to prevention studies have
to be performed, IL-10 might be of use for local treatment of joint.
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Purpose: To verify the involvement of proinflammatory cytokines
IL-17, IL-1β and TNF-α in cartilage vascularization on the pro-
duction of vascular endothelial growth factor (VEGF) by chondro-
cytes isolated from patients with osteoarthritis (OA), rheumatoid
arthritis (RA) and patients with femoral neck fracture (FP), and
to evaluate the production of VEGF by chondrocytes freshly iso-
lated from patients with OA, in comparison with chondrocytes
redifferentiating in micromass.
Methods: Chondrocytes isolated from patients with OA were
maintained in monolayer culture for several passages. Chondro-
